Glen Eagle Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.15K Buy
+2,100
New +$2.68K ﹤0.01% 839
2021
Q3
Sell
-250
Closed -$1.01K 1086
2021
Q2
$1.01K Hold
250
﹤0.01% 972
2021
Q1
$1.07K Hold
250
﹤0.01% 941
2020
Q4
$988 Hold
250
﹤0.01% 909
2020
Q3
$923 Hold
250
﹤0.01% 858
2020
Q2
$853 Hold
250
﹤0.01% 828
2020
Q1
$335 Hold
250
﹤0.01% 801
2019
Q4
$368 Hold
250
﹤0.01% 871
2019
Q3
$523 Hold
250
﹤0.01% 777
2019
Q2
$610 Hold
250
﹤0.01% 757
2019
Q1
$653 Hold
250
﹤0.01% 717
2018
Q4
$753 Hold
250
﹤0.01% 691
2018
Q3
$865 Hold
250
﹤0.01% 682
2018
Q2
$1.18K Hold
250
﹤0.01% 645
2018
Q1
$793 Buy
250
+150
+150% +$604 ﹤0.01% 652
2017
Q4
$490 Sell
100
-100
-50% -$580 ﹤0.01% 625
2017
Q3
$1.37K Sell
200
-200
-50% -$1.26K ﹤0.01% 595
2017
Q2
$2.63K Hold
400
﹤0.01% 526
2017
Q1
$3.2K Buy
400
+200
+100% +$1.68K ﹤0.01% 490
2016
Q4
$1.86K Buy
+200
New +$2.07K ﹤0.01% 496

Other funds holding OPK

Glen Eagle Advisors's OPK Position: Q2 2026 in Review

Glen Eagle Advisors opened a new position in Opko Health (OPK) in Q2 2026: 2,100 shares worth $3.15K. The stake represents ﹤0.01% of the portfolio and ranks #839 among its holdings. This is a return to the name: Glen Eagle Advisors previously reported a position in OPK as recently as Q2 2021.

Glen Eagle Advisors first reported a position in OPK in Q4 2016 and has held it in 20 quarters since. The position peaked at $3.2K in Q1 2017. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Glen Eagle Advisors held 2,100 shares of Opko Health worth $3.15K as of Q2 2026.
  • Opko Health was a new Glen Eagle Advisors position in Q2 2026.
  • Opko Health made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #839 holding.
  • Glen Eagle Advisors first reported a position in Opko Health in Q4 2016 and has held it in 20 quarters since.
  • Glen Eagle Advisors's Opko Health position peaked at $3.2K in Q1 2017.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.